In the 298-page book that is primarily written in English, all of the 67 research groups of the MDC and the clinical groups in the Experimental and Clinical Research Center (ECRC) of the MDC and of the Charité – Universitätsmedizin Berlin give an overview of their work in 2010 – 2011. Research activities at the MDC focus on cardiovascular and metabolic diseases, cancer, diseases of the nervous system and systems biology.
The presentation of the research groups, technology platforms and technology transfer projects provides insight into the research activities of the MDC. “In recent years the scientists of the MDC have again achieved internationally acclaimed results and published them in leading journals,” said Professor Walter Rosenthal, scientific director of the MDC, in his introduction to the research report. In 2010 the MDC ranked 14th on the Thomson Reuters list in the field of molecular biology and genetics, making it the only German research institution to be among the world’s “Top Twenty”.
Furthermore, Professor Rosenthal emphasized the MDC’s extensive participation in excellence clusters and collaborative research centers, the acquisition of eight ERC grants and the award of the Leibniz Prize –the most highly endowed German research prize – to Professor Nikolaus Rajewsky, head of the Berlin Institute for Medical Systems Biology (BIMSB) at the MDC, during the period covered by the report.
“The founding charter of the MDC, which was formulated in 1992, is more relevant than ever,” Professor Rosenthal went on to say. “Its aim is to make laboratory results quickly available to doctors and patients in the hospital – as we say the ʽbench to bedsideʼ approach.” In 2007 the Experimental and Clinical Research Center (ECRC), modeled after Clinical Research Centers (CRC) in the U.S., was founded on Campus Berlin-Buch.
As a joint institution of the MDC and the Charité, the ECRC promotes cooperation between basic scientists and clinical researchers in order to accelerate the transfer of insights gained from laboratory research into medical practice. In the future, according to Prof. Rosenthal, the MDC will take its longstanding and close partnership with the Charité to a new level by developing a common institutional platform. This will ensure that “basic biomedical research and clinical research will benefit even more from each other than in the past.”
The MDC was founded on the Campus Berlin-Buch in 1992. It is a member of the Helmholtz Association of German Research Centres and receives its basic operational funding of approximately 71 million euros a year in a fixed ratio of 90 percent from the Federal Ministry of Education and Research and 10 percent from the state of Berlin. In addition, extramural grants acquired by the researchers are in the two-digit million-euro range each year. At present, approximately 1350 people work at the MDC. These include around 1100 research staff members, of whom around 700 are scientists from Germany and from other countries. Along with its partnership with the Charité, the MDC cooperates closely with the Berlin universities, with the Leibniz-Institut für Molekulare Pharmakologie (FMP), the biotechnology park on Campus Berlin-Buch with its 55 companies and with universities and research institutions inside and outside of Germany.
To receive this new research report, please request a copy from the MDC Press Department.Contact:
Barbara Bachtler | Max-Delbrück-Centrum
The Secret of the Rock Drawings
24.05.2019 | Max-Planck-Institut für Chemie
Chemical juggling with three particles
24.05.2019 | Rheinische Friedrich-Wilhelms-Universität Bonn
A new assessment of NASA's record of global temperatures revealed that the agency's estimate of Earth's long-term temperature rise in recent decades is accurate to within less than a tenth of a degree Fahrenheit, providing confidence that past and future research is correctly capturing rising surface temperatures.
The most complete assessment ever of statistical uncertainty within the GISS Surface Temperature Analysis (GISTEMP) data product shows that the annual values...
Physicists at the University of Basel are able to show for the first time how a single electron looks in an artificial atom. A newly developed method enables them to show the probability of an electron being present in a space. This allows improved control of electron spins, which could serve as the smallest information unit in a future quantum computer. The experiments were published in Physical Review Letters and the related theory in Physical Review B.
The spin of an electron is a promising candidate for use as the smallest information unit (qubit) of a quantum computer. Controlling and switching this spin or...
Engineers at the University of Tokyo continually pioneer new ways to improve battery technology. Professor Atsuo Yamada and his team recently developed a...
With a quantum coprocessor in the cloud, physicists from Innsbruck, Austria, open the door to the simulation of previously unsolvable problems in chemistry, materials research or high-energy physics. The research groups led by Rainer Blatt and Peter Zoller report in the journal Nature how they simulated particle physics phenomena on 20 quantum bits and how the quantum simulator self-verified the result for the first time.
Many scientists are currently working on investigating how quantum advantage can be exploited on hardware already available today. Three years ago, physicists...
'Quantum technologies' utilise the unique phenomena of quantum superposition and entanglement to encode and process information, with potentially profound benefits to a wide range of information technologies from communications to sensing and computing.
However a major challenge in developing these technologies is that the quantum phenomena are very fragile, and only a handful of physical systems have been...
29.04.2019 | Event News
17.04.2019 | Event News
15.04.2019 | Event News
24.05.2019 | Physics and Astronomy
24.05.2019 | Medical Engineering
24.05.2019 | Life Sciences